Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab (Stelara) for Netherton syndrome
MOH_2020-01-01_008584Phase 2Not yet recruiting
- Sponsor
- דר' ליאת סמואלוב
- Start
- May 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ustekinumab in Netherton syndrome (NS), sponsored by דר' ליאת סמואלוב. Planned start May 2019; status: not yet recruiting.
02
Drugs
ustekinumab
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on MOH_2020-01-01_008584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-01-01_008584.